China Demeter Financial Investments (HKSE:08120) Research & Development: HK$0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:08120 China Demeter Financial Investments Ltd HKSE:08120
19 GF Score
Price HK$2.14
GF Value HK$0.18
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is China Demeter Financial Investments Research & Development?

China Demeter Financial Investments HKSE:08120 -1.84% 19 Research & Development is HK$0.00 Mil as of Jun. 2026. GuruFocus rates HKSE:08120 with a GF Score™ of 19/100 and a GF Value™ of HK$0.18 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. China Demeter Financial Investments's Research & Development for the six months ended in Jun. 2026 was HK$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was HK$0.00 Mil.

China Demeter Financial Investments  (HKSE:08120) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

China Demeter Financial Investments Research & Development Related Terms

China Demeter Financial Investments Research & Development Historical Data

* Premium members only.

The historical data trend for China Demeter Financial Investments's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Demeter Financial Investments Research & Development Chart

China Demeter Financial Investments Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

China Demeter Financial Investments Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HKSE:08120
19GF Score
China Demeter Financial Investments Ltd HKSE:08120
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Demeter Financial Investments Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$0.00 Mil mean?
China Demeter Financial Investments (HKSE:08120) has a Research & Development of HK$0.00 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on China Demeter Financial Investments and its competitors.
Is China Demeter Financial Investments' Research & Development too high?
China Demeter Financial Investments' current Research & Development is HK$0.00 Mil. Overall, China Demeter Financial Investments has a GF Score™ of 19/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does China Demeter Financial Investments' Research & Development compare to MCD and SBUX?
China Demeter Financial Investments' Research & Development of HK$0.00 Mil can be compared against companies in the Restaurants industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Restaurants company?
A good Research & Development depends on the Restaurants industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on China Demeter Financial Investments and its competitors. China Demeter Financial Investments's current Research & Development is HK$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Demeter Financial Investments stock overvalued right now?
Based on GuruFocus' analysis, China Demeter Financial Investments (HKSE:08120) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.18, compared to a current price of HK$2.14 — trading 1086.1% above its estimated fair value. The current Research & Development is HK$0.00 Mil. China Demeter Financial Investments' overall GF Score™ is 19/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For China Demeter Financial Investments (HKSE:08120), the current Research & Development is HK$0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Demeter Financial Investments (HKSE:08120) Overvalued in 2026?

Based on GuruFocus' analysis, China Demeter Financial Investments stock appears to be overvalued. The current stock price of HK$2.14 is trading 1086.1% above its estimated GF Value™ of HK$0.18. GuruFocus considers China Demeter Financial Investments to be Significantly Overvalued.

Key valuation signals for HKSE:08120:

  • Research & Development: HK$0.00 Mil
  • GF Value™: HK$0.18 vs. price of HK$2.14 (1086.1% above fair value)
  • GF Score™: 19/100 with 8 warning signs

No single metric tells the full story. See the HKSE:08120 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Demeter Financial Investments Business Description

Address No. 95 Queensway, Office A01, 35th Floor, United Centre, Admiralty, Hong Kong, HKG
China Demeter Financial Investments Ltd is an investment holding company. Its operating segments include money lending, which comprises provision of loan financing in Hong Kong; financial services, which includes advising and dealing in securities and asset management; securities investment, which comprises investment in listed securities; and the food and beverage segment in Hong Kong, which generates maximum revenue. The Group is also engaged in alcoholic beverage distribution and miscellaneous business, which includes sales of premium wine and whisky, trading of miscellaneous goods in Hong Kong, and provision of business advisory services, and children education services, which comprises kindergarten or pre-school education business. It operates in Hong Kong.
19GF Score

Get the complete analysis for HKSE:08120

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.14
Price
HK$0.18
GF Value